Home
Refresh   Tag(s): ; ; ; ;
Add to My Group
July 24, 2007 at 07:35:38

View Ratings | Rate It

CDC Downplays Birth Defects of SSRIs to Boost Sales

submit to twitter
submit to reddit
submit to digg
Tell A Friend

By Evelyn Pringle (about the author)     Page 5 of 5 page(s)

opednews.com     Permalink

"Just yesterday," Mr Kwok states, "I spoke to a mother who birthed a baby with a serious breathing disorder that requires regular use of a nebulizer, a device used to administer medication via liquid mist to the airways, commonly used in treating asthma and other respiratory diseases."

"This young mother is now at risk of losing her job," Mr Kwok reports, "since her infant requires full time care."

He says doctors should be instructed to screen patients who are pregnant or planning to become pregnant and inform them of the risks of SSRIs to a developing fetus. "At least educate this "class" of women," he says, "so they may make informed personal decisions."

"Sure, the loss of this "class" may cost the drug manufacturers some profit," he notes, "but it's the right thing to do and it will save many families a lifetime of torture caring for a sick child like we see over and over again."


The need to recapture pregnant women as customers is crucial for some SSRI makers. For instance, Forest Labs reported that Lexapro and Celexa accounted for 68% of the firm's total sales for the year ending March 31, 2006, in its Annual Report filed with the SEC.

Back in May 2005, researchers from the University of Pittsburgh estimated that in any given year at least 80,000 pregnant women in US are prescribed SSRIs, in JAMA.

Families seeking legal advice for infants born with heart or lung birth defects to mothers who were prescribed Celexa during pregnancy may contact Robert Kwok at Robert Kwok & Associates, LLP at (888)466-5965; http://www.kwoklaw.com/about.php]

Evelyn Pringle
evelyn-pringle@sbcglobal.net

(This article is written as part of a series on Celexa related litigation and is sponsored by Robert Kwok & Associates, LLP)

(Evelyn Pringle is a regular columnist for OpEd News and an investigative journalist focused on exposing corruption in government and corporate America)

Next Page  1  |  2  |  3  |  4  |  5

 

Evelyn Pringle is a columnist for OpEd News and investigative journalist focused on exposing corruption in government and corporate America.

The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.

Contact Author Contact Editor View Authors' Articles

 

Book Recommendations for "Advertising Drugs Forest"
Lauder takes stake in Forest Essentials.(International)(Company overview): An article from: Household
by Gale Reference Team

$9.95

Number of pages: 2
Publisher: Rodman Publishing

View All Book Recommendations

Share this page: (what's this?)                   Tell a Friend: Tell A Friend

FACEBOOK      DIGG THIS      Add This Page to Mr Wong!           NEWSVINE      DEl.ICIO.US      Looksmart Furl      NETSCAPE      My Web      Tag!RawSugar      Blink List     (More...)

Comments: Expand   Shrink   Hide  
No comments

 
Want to post your own comment on this Article? Post Comment


 

 

 

Tell a Friend: Tell A Friend

Copyright © 2002-2009, OpEdNews

Powered by Populum